Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
PCVX
#847
Vaxcyte, Inc. Common Stock
61.740
0
+3.31%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+3.31%
Changement Mensuel
+13.62%
Evolution sur 6 mois
+45.96%
Changement Annuel
+45.96%
Clôture Précédente
59.760
0
Open
61.740
0
Bid
Ask
Low
61.740
0
High
61.740
0
Volume
145
Marchés
Actions des Marchés US
Soins de Santé
PCVX
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
124.64 M
128.76 M
129 M
129.82 M
130.91 M
143.92 M
—
Valuation ratios
Enterprise value
13.19 B
10.15 B
4.52 B
3.91 B
4.43 B
6.47 B
19.34 B
Price to earnings ratio
-24.79
-21.54
-9.46
-7.91
-7.44
-8.2
-33.01
Price to sales ratio
1 113.08
—
—
—
—
—
—
Price to cash flow ratio
26.72
22.06
10.3
9.24
8.83
9.58
37.94
Price to book ratio
1.52
3.02
0.4
0.32
0.38
2.34
3.44
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.03
0.04
0.04
0.05
0.07
0.08
0.24
Return on equity %
0.03
0.04
0.04
0.05
0.07
0.09
0.26
Return on invested capital %
53.9
—
41.35
53.35
60.38
72.9
227.97
Gross margin %
100
—
—
—
—
—
—
Operating margin %
1 655.91
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
1 220.4
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
17.88
12.75
17.7
11.11
8.83
7.91
45.55
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.49
0.91
1.23
0.89
1.05
1.65
4.82
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
17.63
14.32
12.32
12.21
12.57
11.47
48.57
Net current asset value per share
17.9
14.66
12.65
12.61
12.98
11.96
50.2
Tangible book value per share
27.63
27.1
23.58
22.58
21.24
19.73
87.13
Working capital per share
16.9
13.51
11.94
11.48
11.51
10.45
45.37
Book value per share
27.63
27.1
23.58
22.58
21.24
19.73
87.13
Nouvelles
BTIG relève l’objectif de cours de Vaxcyte à 89$ sur l’avantage de couverture du vaccin
BTIG raises Vaxcyte price target to $89 on vaccine breadth edge
Leerink relève l’objectif de cours de Vaxcyte suite à l’expansion du pipeline de vaccins
Leerink raises Vaxcyte stock price target on vaccine pipeline expansion
Vaxcyte, Inc. (PCVX) Q4 2025 Earnings Call Transcript
Ovintiv to Report Q4 Earnings: What's in Store for the Stock?
Vaxcyte clôture une offre publique d’actions ordinaires de 632,5 millions $
Vaxcyte closes $632.5 million public offering of common stock
Vaxcyte fixe le prix de son offre publique d’actions ordinaires à 550 millions $
Vaxcyte prices $550 million public offering of common stock
Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance
Vaxcyte launches $500 million public offering of common stock